Apixaban

Details

Files

Generic Name:

Apixaban

Project Status:

Complete

Therapeutic Area:

Venous thromboembolic events, prevention

Manufacturer:

Bristol-Myers Squibb and Pfizer Canada Alliance

Call for patient/clinician input open:

December 19, 2011

Brand Name:

Eliquis

Project Line:

Reimbursement Review

Project Number:

SR0264-000

Call for patient/clinician input closed:

January 17, 2012

NOC Status at Filing:

Post NOC

Submission Type:

Initial

Indications:

Thromboembolic events, (venous) prevention

Recommendation Type:

List with clinical criteria and/or conditions

Final Recommendation:

June 14, 2012

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Last Updated : December 20, 2011